Flowserve (FLS)
(Delayed Data from NYSE)
$46.59 USD
-0.84 (-1.77%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $46.60 +0.01 (0.02%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$46.59 USD
-0.84 (-1.77%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $46.60 +0.01 (0.02%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth B Momentum A VGM
Zacks News
Flowserve (FLS) Q4 Earnings & Sales Beat Estimates, Rise Y/Y
by Zacks Equity Research
Flowserve's (FLS) Q4 earnings benefit from improved operating leverage and gains from the Flowserve 2.0 transformation strategy.
Why Earnings Season Could Be Great for Flowserve (FLS)
by Zacks Equity Research
Flowserve (FLS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Flowserve (FLS) to Post Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Flowserve's (FLS) fourth-quarter earnings are likely to have gained from strength across the chemical end market. Challenging conditions in the oil & gas end market might have posed a concern.
Flowserve (FLS) to Gain From Strong End Markets Amid Risks
by Zacks Equity Research
Flowserve (FLS) expects to benefit from near-term opportunities in the chemical market and disciplined capital-allocation strategy. However, high debt level poses a concern.
Dull Near-Term Prospects for Industrial Manufacturing Stocks
by Zacks Equity Research
The Manufacturing - General Industrial industry is facing material cost inflation issues. In the long term, technological advancement in manufacturing processes is likely to be a major growth driver.
Flowserve (FLS) Beats Q3 Earnings Estimates, Revises View
by Zacks Equity Research
Flowserve's (FLS) third-quarter 2019 earnings benefit from sales growth, margin improvement and decline in interest expenses. It revises projections for 2019.
Flowserve (FLS) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Flowserve (FLS) delivered earnings and revenue surprises of 5.36% and -1.08%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Flowserve (FLS) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Flowserve's (FLS) third-quarter earnings are likely to have gained from strength across most of its end markets. Challenging conditions in the power market might have posed a concern.
Flowserve (FLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Flowserve (FLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DXPE vs. FLS: Which Stock Is the Better Value Option?
by Zacks Equity Research
DXPE vs. FLS: Which Stock Is the Better Value Option?
IDEX (IEX) Shares Up 31% YTD: What's Driving the Rally?
by Zacks Equity Research
IDEX (IEX) is likely to continue benefiting from solid product portfolio, favorable end markets, buyouts and growth investments.
DXPE vs. FLS: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DXPE vs. FLS: Which Stock Is the Better Value Option?
Flowserve (FLS) Surpasses Q2 Earnings Estimates, Raises View
by Zacks Equity Research
Flowserve's (FLS) second-quarter 2019 results gain from improvement in sales, margins and fall in interest expenses. It increases projections for earnings in 2019.
Flowserve (FLS) Tops Q2 Earnings Estimates
by Zacks Equity Research
Flowserve (FLS) delivered earnings and revenue surprises of 5.88% and -2.15%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Flowserve (FLS) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Flowserve's (FLS) second-quarter earnings are likely to gain from strength across most of its end markets. Challenging conditions in the power market pose a concern.
Flowserve (FLS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Flowserve (FLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Flowserve (FLS) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Flowserve (FLS) have what it takes to be a top stock pick for momentum investors? Let's find out.
TPI Acquires Engineering Team From Berlin-Based EUROS Group
by Zacks Equity Research
TPI Composites' (TPIC) acquisition of an engineering team will allow it to offer complete blade solutions, with large scale application of the technical expertise in blade engineering and mold design.
ABB Suffers from High Costs & Business Integration Issues
by Zacks Equity Research
Rising expenses, high debt levels and ongoing challenges related to the integration of GEIS impede ABB's growth.
The Zacks Analyst Blog Highlights: OSI, Flowserve, Sanmina, Roper and ExOne
by Zacks Equity Research
The Zacks Analyst Blog Highlights: OSI, Flowserve, Sanmina, Roper and ExOne
5 Top Picks as Fed Rate Cut Hopes Dim on Strong Payroll Data
by Nalak Das
Despite strong job addition by professional and business services, health care, transportation and warehousing and construction, it was the manufacturing sector that surprised all.
Here's Why You Should Hold Apogee Stock in Your Portfolio Now
by Zacks Equity Research
With solid bidding and order activity, favorable outlook for North America commercial markets and positive growth projections, Apogee (APOG) is worth retaining in the portfolio at the moment.
Harsco (HSC) Secures $38M Contract From Moon Iron & Steel
by Zacks Equity Research
Harsco's (HSC) contract win from Moon Iron & Steel will enable it to expand footprints in Africa and the Middle East.
EnPro's (NPO) Aseptic Group Buyout to Aid Garlock Business
by Zacks Equity Research
EnPro Industries' (NPO) buyout of Aseptic Group will strengthen business in biopharmaceutical and pharmaceutical industries.
Lindsay (LNN) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Lower backlog, high steel prices and a weak agricultural market are likely to weigh on Lindsay Corporation's (LNN) third-quarter fiscal 2019 results.